The arrival of drug-eluting stents (DES) nearly 2 decades ago ignited a revolution in the field of interventional cardiology. The addition of antiproliferative drugs to the stent platform reduced the rate of in-stent restenosis significantly and increased the number of patients that. to this date. have benefited from percutaneous revascularization. https://parisnaturalfoodes.shop/product-category/herbatint-4r/